Success and failure of vaccines against renin-angiotensin system components.
Therapeutic vaccination pre-dated modern drugs as a possible strategy for treating hypertension. This approach is now being rediscovered, through use of modified angiotensins as immunogens together with carriers and adjuvants. Effective blockade of the renin-angiotensin system (RAS) with treatment twice a year might suit patients who dislike taking drugs on a daily basis and would also be an attractive option for those who have blood pressures in the prehypertensive range, if it can prevent hypertension itself from developing. Proof of concept with a vaccine whose efficacy is easy to measure will encourage development of further vaccines directed against targets such as aldosterone or other pathways where alternative treatments are scarce or absent. Two angiotensin-based vaccines are currently in development: PMD3117 comprises modified angiotensin I coupled to keyhole limpet hemocyanin, and Cyt006-AngQb is a conjugate of angiotensin II linked to virus particles. Early phase II studies in patients with hypertension demonstrated some efficacy, but the vaccines are not as effective as existing inhibitors of the RAS. Large studies now in progress will establish whether further modification of the immunogen or adjuvant is required to boost antibody titers.
Brown
Morris J
MJ
Clinical Pharmacology Unit, University of Cambridge, Cambridge, UK. mjb14@hermes.cam.ac.uk
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000906:Antibodies / Q000097:blood; D001794:Blood Pressure / Q000276:immunology*; D049673:History, 20th Century; D006801:Humans; D006973:Hypertension / Q000266:history / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D007115:Immunization Schedule; D009842:Oligopeptides / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000276:immunology*; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome; D014612:Vaccines / Q000008:administration & dosage / Q000266:history / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000906:Antibodies; C525491:CYT006-AngQb; D009842:Oligopeptides; D014612:Vaccines
Hypertension. 2007 Jul;50(1):161-6
17470717
Hypertension. 1982 Mar-Apr;4(2):185-9
7068178
Lancet. 2005 Jan 15-21;365(9455):217-23
15652604
J Hum Hypertens. 2003 Feb;17(2):81-6
12574784
Clin Sci (Lond). 2004 Aug;107(2):145-7
15104532
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
Hypertension. 2007 Apr;49(4):839-45
17309946
Lancet. 2008 Mar 8;371(9615):821-7
18328929
Heart. 2007 Sep;93(9):1026-33
17488768
Biol Chem. 2008 May;389(5):521-36
18953718
Lancet. 2006 May 27;367(9524):1747-57
16731270
JAMA. 2000 Apr 19;283(15):1967-75
10789664
Ann Pharmacother. 2005 Sep;39(9):1401-8
16076920
Clin Pharmacol Ther. 1999 Oct;66(4):367-73
10546920
Hypertension. 1999 Mar;33(3):850-5
10082498
Hypertension. 1990 Nov;16(5):564-72
2172161
Lancet. 1998 Jun 13;351(9118):1755-62
9635947
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
J Biol Chem. 1976 Aug 25;251(16):4828-32
182680
J Hypertens. 2002 Aug;20(8):1461-4
12172300
J Hypertens. 2007 Jan;25(1):63-72
17143175
Lancet. 2005 Oct 8;366(9493):1267-78
16214597
Circulation. 2008 Aug 12;118(7):773-84
18695203
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Science. 1971 Dec 24;174(4016):1344-6
4332626
Hypertension. 1993 Aug;22(2):139-46
8340149
Lancet. 2005 Sep 10-16;366(9489):895-906
16154016
Hypertension. 1990 Dec;16(6):603-14
2246027
J Allergy Clin Immunol. 2006 Jun;117(6):1470-6
16751015
Lancet. 2002 Dec 14;360(9349):1903-13
12493255
Am Heart J. 1989 Mar;117(3):756-67
2537558
Circulation. 1990 Jun;81(6):1899-910
2188756
Arch Intern Med. 2005 Jun 27;165(12):1410-9
15983291
Hypertension. 2002 Dec;40(6):892-6
12468575
Br J Pharmacol. 2000 Mar;129(6):1178-82
10725266
J Hypertens. 2007 May;25(5):951-8
17414657
World J Surg. 1998 Dec;22(12):1243-5
9841751
Trans Assoc Am Physicians. 1951;64:122-5
14884242
N Engl J Med. 2008 Apr 10;358(15):1547-59
18378520
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4346-50
3108891
J Clin Invest. 1969 Aug;48(8):1506-18
4307701
Hypertension. 2001 Sep;38(3):439-43
11566919
Lancet. 2008 Sep 27;372(9644):1174-83
18757085
J Hypertens. 2003 Jun;21(6):1055-76
12777939
Circ Res. 1975 Nov;37(5):607-14
1192557
Lancet. 2007 Aug 18;370(9587):591-603
17707755
Lancet. 2003 Nov 8;362(9395):1527-35
14615107
N Engl J Med. 2008 Dec 4;359(23):2417-28
19052124
Clin Sci (Lond). 2004 Aug;107(2):167-73
15040783
Br J Clin Pharmacol. 2003 Nov;56(5):505-12
14651724
Intervirology. 2002;45(4-6):212-7
12566703
Hypertension. 2009 Mar;53(3):480-6
19204180